Biotech - Page 4
Stories from Biotech come first, newest first, then stories from connected topics (drug discovery, protein design, AI Science & Health, AI for science, Hub: Tech for Good, biology), each labelled with where it comes from. This view is not indexed by search engines.
Latest
i.AI and Liverpool Plan AI Tools for Young People Into Work
i.AI and Liverpool have agreed a 12-month plan for AI tools aimed at 16 to 24-year-olds who are NEET or at risk, with work starting in January 2027.
Fujitsu, NCCHE and Paradigm Test AI Clinical-Trial Matching
Fujitsu, NCCHE and Paradigm report AI trial-matching from a simulated, single-centre ESMO poster. The results do not guarantee trial participation.
13 Governments Set Out Principles on Countering Scam Centres
Thirteen governments have issued a Statement of Principles on scam centres. It sets out intentions only, with no new sanctions, money or arrests.
MIT Tests a Gel-Free Material for Wearable Ultrasound Patches
MIT has made a gel-free bottlebrush elastomer for wearable ultrasound, shown only in small volunteer demonstrations. It is not clinically validated.
STORM Wins the 2026 ACM Gordon Bell Prize for Climate Modelling
ACM awarded the 2026 Gordon Bell Prize for Climate Modelling to ORNL-led STORM. The figures are as tested; it is not an operational forecast service.
NeuroAxis Glucose-Powered Implant Studied in Diabetic Rats
A NeuroAxis implant powered only by glucose restored glucose tolerance in diabetic rats, a Nature paper says. It has not been tested in people.
Western Cape Government and Microsoft Launch CAPEability AI
Western Cape and Microsoft have launched CAPEability AI, using 83 eCentres and 375 libraries. No participant, budget or job numbers were disclosed.
Canada Opens Standing Offers for Carbon Dioxide Removal Credits
Canada has established national standing offers for carbon dioxide removal credits from 19 projects. The offers allow purchases but do not guarantee them.
Isomorphic Labs and Merck Start an Oncology Collaboration
Isomorphic Labs and Merck (MSD) will design small-molecule candidates for an unnamed oncology target. No deal value, timelines or results were disclosed.
XJTU and EPFL Report 27.96% Certified Perovskite Cells
XJTU and EPFL report perovskite cells at 27.96% certified PCE and 27.84% SPO. The 2,000-hour test used unencapsulated cells under nitrogen at about 45 °C.
Latest on TSN
Explore the TSN Atlas: Every topic we cover, mapped. Click a bubble to dive in.
